Correct Answer : Antiviral Drug
As per a recent study, MK-4482, an experimental antiviral drug, is said to have decreased levels of virus in the lungs of hamsters treated for SARS-CoV-2 infection.
The scientists from the US National Institutes of Health (NIH) published the study in the journal Nature Communications. MK-4482 is now in human clinical trials, and is delivered orally. These data suggest that MK-4482 treatment could mitigate high-risk exposures to the coronavirus.